Ninlaro

Drug Overview
Product Profiles
Ninlaro : Multiple myeloma

Figure 1: Ninlaro for multiple myeloma – SWOT analysis
Figure 2: The authors drug assessment summary of Ninlaro for multiple myeloma
Figure 3: The authors drug assessment summary of Ninlaro for multiple myeloma
Figure 4: Ninlaro sales for multiple myeloma across the US, Japan, and five major EU markets, by country, 2017–26

Table 1: Ninlaro drug profile
Table 2: Ninlaro pivotal trial data in multiple myeloma
Table 3: Ninlaro ongoing late-phase clinical trials in multiple myeloma
Table 4: Ninlaro sales for multiple myeloma across the US, Japan, and five major EU markets, by country ($m), 2017–26
Table 5: Patients treated with Ninlaro across the US, Japan, and five major EU markets, by country, 2017–26